Ann R. Klee - 04 Mar 2024 Form 4 Insider Report for Sotera Health Co (SHC)

Role
Director
Signature
Matthew J. Klaben, Attorney-in-Fact
Issuer symbol
SHC
Transactions as of
04 Mar 2024
Net transactions value
-$82,268
Form type
4
Filing time
06 Mar 2024, 16:41:59 UTC
Previous filing
31 May 2023
Next filing
20 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SHC Common Stock, $0.01 par value per share ("Common Stock") Sale $82,268 -5,750 -6.2% $14.31 86,735 04 Mar 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 4, 2024, the Reporting Person sold a total of 5,750 shares of Common Stock of the Issuer in an underwritten public secondary offering (the "Offering").
F2 Reflects a price equal to the Offering price per share less underwriting discounts and commissions payable thereon, as disclosed in the Issuer's Prospectus 424(b)(7), filed with the United States Securities and Exchange Commission on February 29, 2024.
F3 Consists of 15,712 Restricted Stock Units and 71,023 shares of Common Stock, including 62,537 shares of vested Common Stock and 8,486 shares of unvested Common Stock. The unvested shares of Common Stock will vest on a daily basis pro rata through May 27, 2025.

Remarks:

The Power of Attorney for Ms. Klee is filed as an exhibit to the Form 3 filed with the Securities and Exchange Commission on November 20, 2020, which is hereby incorporated by reference.